503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
View analysts' price targets and recommendations, and compare them with competitors.
$601.38
Analysts expect the stock price to increase by 17.94%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
198.27B
Revenue has increased from the previous period.
17.96%
Revenue growth rate has increased from the previous period.
100.24B
EBITDA has increased from the previous period.
50.56%
EBITDA margin has increased from the previous period.
85.78B
EBIT has increased from the previous period.
43.26%
EBIT margin has decreased from the previous period.
14.46B
Depreciation has increased from the previous period.
104.75B
Total cash has decreased from the previous period.
52.83%
Cash percentage has decreased from the previous period.
44.26B
Receivables have increased from the previous period.
22.32%
Receivables percentage has decreased from the previous period.
3.74B
Inventories have increased from the previous period.
1.89%
Inventory percentage has increased from the previous period.
19.00B
Accounts payable has increased from the previous period.
9.58%
Payables percentage has increased from the previous period.
-23.89B
Capital expenditure has increased from the previous period.
-12.05%
CapEx percentage has decreased from the previous period.
8.39%
WACC is unchanged from the previous period.
8.53%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
0.90
Beta is unchanged from the previous period.
7.47B
Diluted shares outstanding is unchanged from the previous period.
97.85B
Total debt is unchanged from the previous period.
3.37T
Total equity is unchanged from the previous period.
3.47T
Total capital is unchanged from the previous period.
2.82%
Debt weighting is unchanged from the previous period.
97.18%
Equity weighting is unchanged from the previous period.
74.53B
EBIAT has increased from the previous period.
61.62B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
3.24T
Terminal value is unchanged from the previous period.
2.57T
Enterprise value has decreased from the previous period.
79.54B
Net debt is unchanged from the previous period.
2.49T
Equity value has decreased from the previous period.
334.02
Equity value per share has decreased from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
79.47B
The estimated revenue has increased from the previous period.
30.65B
The estimated EBITDA has increased from the previous period.
2.52
The estimated EPS has increased from the previous period.
21.32B
The estimated net income has increased from the previous period.
26.16B
The estimated EBIT has increased from the previous period.
19.60B
The estimated SG&A expenses have increased from the previous period.
